| Jacqueline Nicole Trombley, LCSW-C | |
|
808 Olney Sandy Spring Rd Ste 2d, Sandy Spring, MD 20860-1055 | |
| (240) 389-5719 | |
| Not Available |
| Full Name | Jacqueline Nicole Trombley |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 13 Years |
| Location | 808 Olney Sandy Spring Rd Ste 2d, Sandy Spring, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558747832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 17383 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Families First Counseling And Psychiatry Llc | 4284986266 | 19 |
| Families First Counseling And Psychiatry Llc | 4284986266 | 19 |
News Archive
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.
Today RetireSafe, representing 400,000 senior citizen supporters across America, urged seniors nationwide to call on Congress to save high-quality physician hospitals from the restrictive health care reform language now pending in Congress. House and Senate "reform" efforts would ration high-quality physician hospital care to Medicare patients, as a "cost savings."
At a roundtable of key business, labor, government, community, and health care leaders from across the nation sponsored by the Department of Health and Human Services (HHS), Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), issued the following statement on progress in providing the highest value health care to patients:
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
› Verified 3 days ago
| Entity Name | Hefuna Mental Health Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629470547 PECOS PAC ID: 3577783240 Enrollment ID: O20141002000365 |
News Archive
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.
Today RetireSafe, representing 400,000 senior citizen supporters across America, urged seniors nationwide to call on Congress to save high-quality physician hospitals from the restrictive health care reform language now pending in Congress. House and Senate "reform" efforts would ration high-quality physician hospital care to Medicare patients, as a "cost savings."
At a roundtable of key business, labor, government, community, and health care leaders from across the nation sponsored by the Department of Health and Human Services (HHS), Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), issued the following statement on progress in providing the highest value health care to patients:
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
› Verified 3 days ago
| Entity Name | Families First Counseling And Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881104347 PECOS PAC ID: 4284986266 Enrollment ID: O20181003001666 |
News Archive
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.
Today RetireSafe, representing 400,000 senior citizen supporters across America, urged seniors nationwide to call on Congress to save high-quality physician hospitals from the restrictive health care reform language now pending in Congress. House and Senate "reform" efforts would ration high-quality physician hospital care to Medicare patients, as a "cost savings."
At a roundtable of key business, labor, government, community, and health care leaders from across the nation sponsored by the Department of Health and Human Services (HHS), Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), issued the following statement on progress in providing the highest value health care to patients:
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Nicole Trombley, LCSW-C 808 Olney Sandy Spring Rd Ste 2d, Sandy Spring, MD 20860-1055 Ph: (240) 389-5719 | Jacqueline Nicole Trombley, LCSW-C 808 Olney Sandy Spring Rd Ste 2d, Sandy Spring, MD 20860-1055 Ph: (240) 389-5719 |
News Archive
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.
Today RetireSafe, representing 400,000 senior citizen supporters across America, urged seniors nationwide to call on Congress to save high-quality physician hospitals from the restrictive health care reform language now pending in Congress. House and Senate "reform" efforts would ration high-quality physician hospital care to Medicare patients, as a "cost savings."
At a roundtable of key business, labor, government, community, and health care leaders from across the nation sponsored by the Department of Health and Human Services (HHS), Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), issued the following statement on progress in providing the highest value health care to patients:
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
› Verified 3 days ago
Roger Roark, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 17301 Quaker Ln, Sandy Spring, MD 20860 Phone: 410-292-4191 | |
Melanie Stettz, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 17619 Norwood Rd, Sandy Spring, MD 20860 Phone: 202-487-8424 | |
Mario Alexander Esposito Faraone, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 913 Olney Sandy Spring Rd, Sandy Spring, MD 20860 Phone: 301-570-4050 |